+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Biopsy Devices - Company Evaluation Report, 2024

  • PDF Icon

    Report

  • 140 Pages
  • May 2025
  • Region: Global
  • Markets and Markets
  • ID: 6096956
Description Jump to:
The Biopsy Devices Companies Quadrant is a comprehensive industry analysis that provides valuable insights into the global market for Biopsy Devices. This quadrant offers a detailed evaluation of key market players, technological advancements, product innovations, and industry trends. Over 140 companies were evaluated, of which the Top 15 Biopsy Devices companies were categorized and recognized as the quadrant leaders.

Material informatics is a software platform that applies informatics principles to materials science and engineering, enhancing the understanding, utilization, selection, development, and discovery of materials. This innovative technology is designed for the rapid and efficient acquisition, management, analysis, and sharing of diverse materials data, helping to minimize the time, cost, and risk involved in the development, production, and deployment of new materials. Material informatics is widely used across various fields, including chemicals and pharmaceuticals, materials science, and manufacturing, with applications spanning industries such as automotive, aerospace, electronics, and semiconductors, energy, and food science.

The 360 Quadrant maps the Biopsy Devices companies based on criteria such as revenue, geographic presence, growth strategies, investments, and sales strategies for the market presence of the Biopsy Devices quadrant. The top criteria for product footprint evaluation included Product (Needle-based biopsy instrument, visualization device/system, brush biopsy instrument, biopsy accessory, and robotic biopsy device), Technology (Ultrasound-guided biopsy, stereotactic-guided biopsy, and other technologies), and Application (oncology, gastroenterology, bone & bone marrow biopsy, and other applications).

Key Players:

The key strategies adopted by the market's leading players include product approvals, expansions, acquisitions, and collaborations. The prominent players in the global biopsy devices market are BD (US), Devicor medical products, Inc (US), Medtronic (Ireland), Cardinal Health (US), B. Braun SE (Germany), Hologic, Inc (US), Olympus Corporation (Japan), Boston Scientific Corporation (US), FUJIFILM Corporation (Japan), Stryker (US), Teleflex Incorporated (US), CONMED Corporation (US), Merit Medical Systems (US), Johnson & Johnson Services, Inc. (US), Cook Group (US), MicroPort Scientific Corporation (China), Argon Medical Devices (US), INRAD, Inc (US), Summit Medical LLC (US), TransMed7, LLC (US), Dr. Japan Co., Ltd. (Japan), IZI Medical Products (US), Planmed Oy (Finland), Advin Health Care (India), and Trivitron Healthcare (India).

BD (Becton Dickinson and Company)

BD is a prominent player known for its broad product portfolio in biopsy technologies and a robust global distribution network. The acquisition of C. R. Bard has fortified its position, enhancing its biopsy segment capabilities, particularly in soft tissue biopsy systems. BD's commitment to minimally invasive diagnostic solutions, coupled with substantial R&D investments, underscores its market dominance. The company's emphasis on providing high-precision biopsy solutions aligns well with its strategy to maintain a competitive edge.

Devicor Medical Products, Inc.

Devicor Medical, with its innovation-driven approach, offers advanced breast biopsy systems and tissue markers. The company's focus on operational efficiency and strategic brand positioning ensures a significant right to win in the market. The introduction of the Mammotome Trace system highlights Devicor's emphasis on enhancing biopsy procedures, with a keen focus on R&D for expanding into other cancer applications, such as lung and liver cancer.

Medtronic

Medtronic's extensive portfolio of advanced biopsy solutions and its strategic acquisitions bolster its strong global presence. The company excels in developing high-precision, minimally invasive biopsy devices that cater to diverse clinical needs. Strategic collaborations expand its reach and support the adoption of its innovative solutions across various healthcare settings. Medtronic's integration of robotics and AI into its technological offerings enhances its status as a leader in the precision diagnostics market.

Table of Contents

1 Introduction
1.1 Market Definition
1.2 Inclusions & Exclusions
1.3 Stakeholders
2 Executive Summary
3 Market Overview
3.1 Introduction
3.2 Market Dynamics
3.2.1 Drivers
3.2.1.1 Rising Prevalence of Cancer
3.2.1.2 Increasing Preference for Minimally Invasive Surgeries
3.2.1.3 Initiatives Undertaken by Governments and Global Health Organizations
3.2.1.4 Increased Number of Hospitals and Diagnostic Centers
3.2.1.5 Improved Reimbursement Policies
3.2.2 Restraints
3.2.2.1 Increasing Product Recalls
3.2.2.2 High Risk of Infections
3.2.3 Opportunities
3.2.3.1 Technological Advancements
3.2.3.2 Growing Investments in Emerging Economies
3.2.4 Challenges
3.2.4.1 Underdeveloped Healthcare Infrastructure in Emerging Economies
3.3 Industry Trends
3.3.1 Minimally Invasive Procedures
3.3.2 Robotic-Assisted Biopsy Devices
3.3.3 Liquid Biopsy Technology
3.4 Technology Analysis
3.4.1 Key Technologies
3.4.1.1 Robotic-Assisted Biopsy Devices
3.4.1.2 Optical Biopsy Technologies
3.4.1.3 Minimally Invasive Biopsy Devices
3.4.2 Complementary Technologies
3.4.2.1 Imaging Technologies
3.4.2.2 Tissue Analysis Technologies
3.4.2.3 Artificial Intelligence
3.4.3 Adjacent Technologies
3.4.3.1 Digital Pathology and AI Integration
3.4.3.2 Precision Medicine Tools
3.4.3.3 Advanced Needle and Probe Technologies
3.5 Porter's Five Forces Analysis
3.5.1 Threat from New Entrants
3.5.2 Bargaining Power of Suppliers
3.5.3 Bargaining Power of Buyers
3.5.4 Threat from Substitutes
3.5.5 Intensity of Competitive Rivalry
3.6 Patent Analysis
3.6.1 Patent Publication Trends in Biopsy Devices Market
3.6.2 Insights: Jurisdiction and Top Applicant Analysis
3.7 Key Conferences & Events
3.8 Ecosystem Analysis
3.9 Supply Chain Analysis
3.10 Trends/Disruptions Impacting Customer Business
3.11 Impact of AI on Biopsy Devices Market
4 Competitive Landscape
4.1 Overview
4.2 Key Player Strategies/Right to Win
4.2.1 Overview of Strategies Adopted by Key Players in Biopsy Devices Market
4.3 Revenue Analysis
4.4 Market Share Analysis
4.5 Company Evaluation Matrix: Key Players, 2023
4.5.1 Stars
4.5.2 Emerging Leaders
4.5.3 Pervasive Players
4.5.4 Participants
4.5.5 Company Footprint: Key Players, 2023
4.5.5.1 Company Footprint
4.5.5.2 Region Footprint
4.5.5.3 Product Footprint
4.5.5.4 Technology Footprint
4.5.5.5 Application Footprint
4.5.5.6 End-user Footprint
4.6 Company Evaluation Matrix: Startups/SMEs, 2023
4.6.1 Progressive Companies
4.6.2 Responsive Companies
4.6.3 Dynamic Companies
4.6.4 Starting Blocks
4.6.5 Competitive Benchmarking: Startups/SMEs, 2023
4.7 Company Valuation & Financial Metrics
4.7.1 Company Valuation
4.7.2 Financial Metrics
4.8 Brand/Product Comparison
4.9 Competitive Scenario
4.9.1 Product Launches & Approvals
4.9.2 Deals
4.9.3 Expansions
5 Company Profiles
5.1 Key Players
5.1.1 Bd (Becton, Dickinson and Company)
5.1.1.1 Business Overview
5.1.1.2 Products Offered
5.1.1.3 Recent Developments
5.1.1.3.1 Deals
5.1.1.4 Analyst's View
5.1.1.4.1 Key Strengths
5.1.1.4.2 Strategic Choices
5.1.1.4.3 Weaknesses & Competitive Threats
5.1.2 Devicor Medical Products, Inc
5.1.2.1 Business Overview
5.1.2.2 Products Offered
5.1.2.3 Recent Developments
5.1.2.3.1 Product Launches & Approvals
5.1.2.4 Analyst's View
5.1.2.4.1 Key Strengths
5.1.2.4.2 Strategic Choices
5.1.2.4.3 Weaknesses & Competitive Threats
5.1.3 Medtronic
5.1.3.1 Business Overview
5.1.3.2 Products Offered
5.1.3.3 Analyst's View
5.1.3.3.1 Key Strengths
5.1.3.3.2 Strategic Choices
5.1.3.3.3 Weaknesses & Competitive Threats
5.1.4 Cardinal Health
5.1.4.1 Business Overview
5.1.4.2 Products Offered
5.1.4.3 Analyst's View
5.1.4.3.1 Key Strengths
5.1.4.3.2 Strategic Choices
5.1.4.3.3 Weaknesses & Competitive Threats
5.1.5 Hologic, Inc.
5.1.5.1 Business Overview
5.1.5.2 Products Offered
5.1.5.3 Recent Developments
5.1.5.3.1 Deals
5.1.5.3.2 Other Developments
5.1.5.4 Analyst's View
5.1.5.4.1 Key Strengths
5.1.5.4.2 Strategic Choices
5.1.5.4.3 Weaknesses & Competitive Threats
5.1.6 B. Braun SE
5.1.6.1 Business Overview
5.1.6.2 Products Offered
5.1.7 Olympus Corporation
5.1.7.1 Business Overview
5.1.7.2 Products Offered
5.1.7.3 Recent Developments
5.1.7.3.1 Deals
5.1.8 Boston Scientific Corporation
5.1.8.1 Business Overview
5.1.8.2 Products Offered
5.1.9 Fujifilm Corporation
5.1.9.1 Business Overview
5.1.9.2 Products Offered
5.1.10 Stryker
5.1.10.1 Business Overview
5.1.10.2 Products Offered
5.1.11 Teleflex Incorporated
5.1.11.1 Business Overview
5.1.11.2 Products Offered
5.1.12 Conmed Corporation
5.1.12.1 Business Overview
5.1.12.2 Products Offered
5.1.13 Merit Medical Systems
5.1.13.1 Business Overview
5.1.13.2 Products Offered
5.1.14 Johnson & Johnson Services, Inc.
5.1.14.1 Business Overview
5.1.14.2 Products Offered
5.1.15 Cook Group
5.1.15.1 Business Overview
5.1.15.2 Products Offered
5.1.15.3 Recent Developments
5.1.15.3.1 Product Launches & Approvals
5.2 Other Players
5.2.1 Microport Scientific Corporation
5.2.2 Argon Medical Devices
5.2.3 Inrad, Inc.
5.2.4 Summit Medical LLC
5.2.5 Transmed7, LLC
5.2.6 Dr. Japan Co. Ltd.
5.2.7 Izi Medical Products
5.2.8 Planmed Oy
5.2.9 Advin Health Care
5.2.10 Trivitron Healthcare
6 Appendix
6.1 Research Methodology
6.1.1 Research Data
6.1.1.1 Secondary Data
6.1.1.2 Primary Data
6.1.2 Research Assumptions
6.1.3 Research Limitations
6.1.4 Risk Assessment
6.2 Company Evaluation Matrix: Methodology
List of Tables
Table 1 Biopsy Devices Market: Inclusions & Exclusions
Table 2 Porter's Five Forces Analysis
Table 3 List of Patents in Biopsy Devices Market, 2014-2024
Table 4 Biopsy Devices Market: Key Conferences & Events, 2025
Table 5 Overview of Strategies Adopted by Key Players in Biopsy Devices Market
Table 6 Biopsy Devices Market: Degree of Competition
Table 7 Biopsy Devices Market: Region Footprint
Table 8 Biopsy Devices Market: Product Footprint
Table 9 Biopsy Devices Market: Technology Footprint
Table 10 Biopsy Devices Market: Application Footprint
Table 11 Biopsy Devices Market: End-user Footprint
Table 12 Biopsy Devices Market: Detailed List of Key Startups/SMEs
Table 13 Biopsy Devices Market: Competitive Benchmarking of Key Emerging Players/Startups, by Region
Table 14 Biopsy Devices Market: Product Launches & Approvals, January 2021-January 2025
Table 15 Biopsy Devices Market: Deals, January 2021-January 2025
Table 16 Biopsy Devices Market: Expansions, January 2021-January 2025
Table 17 Bd (Becton, Dickinson and Company): Company Overview
Table 18 Bd (Becton, Dickinson and Company): Products Offered
Table 19 Bd (Becton, Dickinson and Company): Deals, January 2021-January 2025
Table 20 Devicor Medical Products, Inc.: Company Overview
Table 21 Devicor Medical Products, Inc.: Products Offered
Table 22 Devicor Medical Products, Inc.: Product Launches & Approvals, January 2021-January 2025
Table 23 Medtronic: Company Overview
Table 24 Medtronic: Products Offered
Table 25 Cardinal Health: Company Overview
Table 26 Cardinal Health: Products Offered
Table 27 Hologic, Inc.: Company Overview
Table 28 Hologic, Inc.: Products Offered
Table 29 Hologic, Inc.: Deals, January 2021-January 2025
Table 30 B. Braun SE: Company Overview
Table 31 B. Braun SE: Products Offered
Table 32 Olympus Corporation: Company Overview
Table 33 Olympus Corporation: Products Offered
Table 34 Olympus Corporation: Deals, January 2021-January 2025
Table 35 Boston Scientific Corporation: Company Overview
Table 36 Boston Scientific Corporation: Products Offered
Table 37 Fujifilm Corporation: Company Overview
Table 38 Fujifilm Corporation: Products Offered
Table 39 Stryker: Company Overview
Table 40 Stryker: Products Offered
Table 41 Teleflex Incorporated: Company Overview
Table 42 Teleflex Incorporated: Products Offered
Table 43 Conmed Corporation: Company Overview
Table 44 Conmed Corporation: Products Offered
Table 45 Merit Medical Systems: Company Overview
Table 46 Merit Medical Systems: Products Offered
Table 47 Merit Medical Systems: Product Launches & Approvals, January 2021-January 2025
Table 48 Merit Medical Systems: Deals, January 2021-January 2025
Table 49 Johnson & Johnson Services, Inc.: Company Overview
Table 50 Johnson & Johnson Services Inc.: Products Offered
Table 51 Cook Group: Company Overview
Table 52 Cook Group: Products Offered
Table 53 Cook Group: Product Launches & Approvals, January 2021-January 2025
Table 54 Research Assumptions
List of Figures
Figure 1 Biopsy Devices Market, by Product, 2024 vs. 2030 (USD Million)
Figure 2 Biopsy Devices Market, by Needle-based Biopsy Instrument, 2024 vs. 2030 (USD Million)
Figure 3 Biopsy Devices Market, by Core Needle Biopsy, 2024 vs. 2030 (USD Million)
Figure 4 Biopsy Devices Market, by Technology, 2024 vs. 2030 (USD Million)
Figure 5 Biopsy Devices Market, by Application, 2024 vs. 2030 (USD Million)
Figure 6 Biopsy Devices Market, by End-user, 2024 vs. 2030 (USD Million)
Figure 7 North America Accounted for Largest Market Share in 2023
Figure 8 Biopsy Devices Market: Drivers, Restraints, Opportunities, and Challenges
Figure 9 Trends in Biopsy Devices Market
Figure 10 Biopsy Devices Market: Porter's Five Forces Analysis
Figure 11 Number of Patents Published, 2014-2025
Figure 12 Top Ten Patent Owners for Biopsy Devices, 2014-2025
Figure 13 Top Applicants for Biopsy Devices, 2014-2025
Figure 14 Biopsy Devices Market: Ecosystem Analysis
Figure 15 Biopsy Devices Market: Supply Chain Analysis
Figure 16 Revenue Shift for Biopsy Devices Market
Figure 17 Use of AI/Gen AI in Biopsy Procedures
Figure 18 Revenue Analysis of Key Players, 2021-2023 (USD Million)
Figure 19 Market Share Analysis, 2023
Figure 20 Ranking of Key Players in Biopsy Devices Market, 2023
Figure 21 Biopsy Devices Market: Company Evaluation Matrix (Key Players), 2023
Figure 22 Biopsy Devices Market: Company Footprint
Figure 23 Biopsy Devices Market: Company Evaluation Matrix (Startups/SMEs), 2023
Figure 24 Year-To-Date (Ytd) Price Total Return and 5-Year Stock Beta of Key Vendors
Figure 25 EV/Ebitda of Key Players
Figure 26 Biopsy Devices Market: Brand/Product Comparative Analysis
Figure 27 Bd (Becton, Dickinson and Company): Company Snapshot (2024)
Figure 28 Devicor Medical Products, Inc.: Company Snapshot (2023)
Figure 29 Medtronic: Company Snapshot (2024)
Figure 30 Cardinal Health: Company Snapshot (2024)
Figure 31 Hologic, Inc.: Company Snapshot (2024)
Figure 32 B. Braun SE: Company Snapshot (2023)
Figure 33 Olympus Corporation: Company Snapshot (2024)
Figure 34 Boston Scientific Corporation: Company Snapshot (2023)
Figure 35 Fujifilm Corporation: Company Snapshot (2024)
Figure 36 Stryker: Company Snapshot (2023)
Figure 37 Teleflex Incorporated: Company Snapshot (2023)
Figure 38 Conmed Corporation: Company Snapshot (2023)
Figure 39 Merit Medical Systems: Company Snapshot (2023)
Figure 40 Johnson & Johnson Services, Inc.: Company Snapshot (2023)
Figure 41 Research Design

Companies Mentioned

  • Bd (Becton, Dickinson and Company)
  • Devicor Medical Products, Inc
  • Medtronic
  • Cardinal Health
  • Hologic, Inc.
  • B. Braun SE
  • Olympus Corporation
  • Boston Scientific Corporation
  • Fujifilm Corporation
  • Stryker
  • Teleflex Incorporated
  • Conmed Corporation
  • Merit Medical Systems
  • Johnson & Johnson Services, Inc.
  • Cook Group
  • Microport Scientific Corporation
  • Argon Medical Devices
  • Inrad, Inc.
  • Summit Medical LLC
  • Transmed7, LLC
  • Dr. Japan Co. Ltd.
  • Izi Medical Products
  • Planmed Oy
  • Advin Health Care
  • Trivitron Healthcare

Related Topics

Related Reports

Biopsy Devices Market by Product (Core Needle Biopsy (Automatic, Disposable), Technology (Ultrasound,Stereotactic), Application (Oncology, Gastroenterology, Bone & Bone Marrow Biopsy), End User (Diagnostic Imaging Centres) - Global Forecast to 2030 - Product Image

Biopsy Devices Market by Product (Core Needle Biopsy (Automatic, Disposable), Technology (Ultrasound,Stereotactic), Application (Oncology, Gastroenterology, Bone & Bone Marrow Biopsy), End User (Diagnostic Imaging Centres) - Global Forecast to 2030

  • Report
  • 504 Pages
  • Global
From
Breast Biopsy Market Report 2025 - Product Image

Breast Biopsy Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Breast Biopsy Devices Market by Product, Procedure, Application, End User - Global Forecasts to 2030 - Product Image

Breast Biopsy Devices Market by Product, Procedure, Application, End User - Global Forecasts to 2030

  • Report
  • 290 Pages
  • Global
From
Vacuum-assisted Biopsy Device Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Product Type - Product Image

Vacuum-assisted Biopsy Device Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Product Type

  • Report
  • 90 Pages
  • Global
From
Biopsy Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030 - Product Image

Biopsy Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030

  • Report
  • 100 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.